Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

1.1K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.1K
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

456
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
456
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

4.1K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.1K
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

428
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
428
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

1.0K
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.0K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

1.2K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.2K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Using AI Disagreement to Expose Gaps in Coverage Rules.

JAMA·2026
Same author

Phenotypic prediction of missense variants via deep contrastive learning.

Nature biomedical engineering·2026
Same author

Scaling medical AI across clinical contexts.

Nature medicine·2026
Same author

Heterogenous effect of automated alerts on mortality.

Journal of the American Medical Informatics Association : JAMIA·2025
Same author

The missing value of medical artificial intelligence.

Nature medicine·2025
Same author

Heterogeneous Effect of Automated Alerts on Mortality.

medRxiv : the preprint server for health sciences·2025

相关实验视频

Updated: Feb 21, 2026

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

7.1K

用人工智能预测心力衰竭中的左心室缩功能障碍.

Teya Bergamaschi1,2,3,4, Tiffany Yau2,3,4,5, Payal Chandak6,7,8

  • 1Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.

EClinicalMedicine
|February 20, 2026
PubMed
概括
此摘要是机器生成的。

一个新的深度学习模型,PULSE-HF,准确地预测使用心电图的心力衰竭患者左心室喷射率 (LVEF) 的恶化. 该工具有助于识别有风险的个体,以便及时进行干预.

关键词:
深度学习是一种深度学习.心脏衰竭是因为心脏衰竭.在LVEF中,我们可以看到LVEF.

更多相关视频

Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
04:05

Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis

Published on: June 30, 2023

2.9K
Murine Echocardiography of Left Atrium, Aorta, and Pulmonary Artery
08:17

Murine Echocardiography of Left Atrium, Aorta, and Pulmonary Artery

Published on: February 20, 2017

15.1K

相关实验视频

Last Updated: Feb 21, 2026

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

7.1K
Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
04:05

Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis

Published on: June 30, 2023

2.9K
Murine Echocardiography of Left Atrium, Aorta, and Pulmonary Artery
08:17

Murine Echocardiography of Left Atrium, Aorta, and Pulmonary Artery

Published on: February 20, 2017

15.1K

科学领域:

  • 心脏病学 心脏病学
  • 人工智能的人工智能
  • 医学诊断 医学诊断 医学诊断

背景情况:

  • 对左心室功能的客观评估对于指导心力衰竭 (HF) 治疗至关重要.
  • 左心室喷射分数 (LVEF) 是动态的,下降与增加的发病率和死亡率有关.
  • 识别患有LVEF下降风险的患者可以改善预后,并使及时干预成为可能.

研究的目的:

  • 开发和验证一种深度学习模型 (PULSE-HF),该模型可以从心力电图 (ECG) 预测心力衰竭患者的左心室缩功能变化.
  • 评估模型在一年内识别可能LVEF低于40%的患者的能力.

主要方法:

  • 开发了一个深度学习模型,PULSE-HF,将12导心电图波形与先前的LVEF测量集成在一起.
  • 追溯地开发和测试该模型从一家医院的数据 (2000年1月至2021年6月).
  • 在两个额外的医院的回顾性队列上对该模型进行了外部验证 (数据收集于2000年1月至2021年6月和2008-2019年之间).

主要成果:

  • PULSE-HF表现出强大的区分能力,接收器运行特征曲线 (AUROC) 下的面积在三个HF队列中为87.5-91.4%,用于预测一年内LVEF<40%.
  • 在基线LVEF>40%的患者中,PULSE-HF确定了那些 LVEF恶化风险较高的患者,AUROC为81.6-86.3%.
  • 模型的性能在各种子组中保持一致,简化的领先I版本显示了与12领先模型相似的性能.

结论:

  • PULSE-HF强有力的预测恶化LVEF在患者之前诊断为心力衰竭.
  • 这种深度学习方法提供了一个有价值的平台,用于识别患有恶化缩功能障碍风险增加的患者.
  • 该模型能够从ECG预测LVEF下降的能力可以促进心力衰竭护理中的积极管理策略.